|This Slide: #40 of 100|
Slide #40. McKesson Corporation — Celesio
McKesson Corporation (NYSE:MCK)
McKesson Corporation (NYSE:MCK), a leading North American healthcare services and information technology company, announced today that it has reached an agreement with Franz Haniel & Cie. GmbH ("Haniel") to acquire their entire holding of Celesio shares for EUR 23.50 per share. In a separate and subsequent agreement, McKesson also announced the acquisition of Celesio convertible bonds from Elliott. These agreements are not subject to any closing conditions and the transactions are expected to close within 10 business days. After the close of the agreements with Haniel and Elliott, McKesson will exceed 75% ownership of Celesio shares on a fully diluted basis.
McKesson is engaged in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. Co.'s segments include: U.S. Pharmaceutical, which distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs; International, which provides distribution and services to wholesale, institutional, and retail customers; Medical-Surgical Solutions, which provides medical-surgical supply distribution, logistics, and other services to healthcare providers; and Prescription Technology Solutions, which brings together CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation.
McKesson SEC Filing Email Alerts Service
Open the MCK Page at The Online Investor »
Free MCK Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Strong Buy (3.59 out of 4)